Immunome IMNM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's accounts payable?
- Immunome (IMNM) reported accounts payable of $5.53M in Q1 2026.
- How has Immunome's accounts payable changed year-over-year?
- Immunome's accounts payable decreased by 39.4% year-over-year, from $9.13M to $5.53M.
- What is the long-term trend for Immunome's accounts payable?
- Over 4 years (2021 to 2025), Immunome's accounts payable has grown at a 20.3% compound annual growth rate (CAGR), from $11.1M to $23.27M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.